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Abstract
Translating a set of disease regions into insight about pathogenic mechanisms requires not only the ability to identify the
key disease genes within them, but also the biological relationships among those key genes. Here we describe a statistical
method, Gene Relationships Among Implicated Loci (GRAIL), that takes a list of disease regions and automatically assesses
the degree of relatedness of implicated genes using 250,000 PubMed abstracts. We first evaluated GRAIL by assessing its
ability to identify subsets of highly related genes in common pathways from validated lipid and height SNP associations
from recent genome-wide studies. We then tested GRAIL, by assessing its ability to separate true disease regions from many
false positive disease regions in two separate practical applications in human genetics. First, we took 74 nominally
associated Crohn’s disease SNPs and applied GRAIL to identify a subset of 13 SNPs with highly related genes. Of these, ten
convincingly validated in follow-up genotyping; genotyping results for the remaining three were inconclusive. Next, we
applied GRAIL to 165 rare deletion events seen in schizophrenia cases (less than one-third of which are contributing to
disease risk). We demonstrate that GRAIL is able to identify a subset of 16 deletions containing highly related genes; many
of these genes are expressed in the central nervous system and play a role in neuronal synapses. GRAIL offers a statistically
robust approach to identifying functionally related genes from across multiple disease regions—that likely represent key
disease pathways. An online version of this method is available for public use (http://www.broad.mit.edu/mpg/grail/).
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Introduction
An emerging challenge in genomics is the ability to examine
multiple disease regions within the human genome, and to
recognize a subset of key genes that are involved in a common
cellular process or pathway. This is a key task to translate
experimentally ascertained disease regions into meaningful
understanding about pathogenesis. The importance of this
challenge has been highlighted by advances in human genetics
that are facilitating the rapid discovery of disease regions in the
form of genomic regions around associated SNPs (single nucleotide
polymorphisms) [1–6] or CNVs (copy number variants) [7–10].
These disease regions often overlap multiple genes – though only
one is typically relevant to pathogenesis and the remaining are
spuriously implicated by proximity. The difficulty of this task is
heightened by the limited state of cataloged interactions,
pathways, and functions for the vast majority of genes. However,
undefined gene relationships might often be conjectured from the
literature, even if they are not explicitly described yet.
The general strategy of using function to prioritize genes in
disease regions has been substantially explored [11–18]. However,
predicted disease genes have not, in general, been easily validated.
Thus far, published approaches have utilized a range of codified
gene information including protein-interaction maps, gene
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expression data, carefully constructed gene networks based on
multiple information sources, predefined gene sets and pathways,
and disease-related keywords. We propose, instead, to use a
flexible metric of gene relatedness that not only captures clearly
established close gene relationships, but also has the ability to
capture potential undocumented or distant ones. Such a metric
may be a more powerful tool to approach this problem rather then
relying on incomplete databases of gene functions, interactions, or
relationships.
To this end, we use established statistical text mining
approaches to quantify relatedness between two genes – specifically,
gene relatedness is the degree of similarity in the text describing
them within article abstracts. The published literature represented
in online PubMed abstracts encapsulates years of research on
biological mechanisms. We and others have shown the great utility
of statistical text mining to rapidly obtain functional information
about genes, including protein-protein interactions, gene function
annotation, and measuring gene-gene similarity [19–22]. Text is
an abundant and underutilized resource in human genetics, and
currently a total of 140,000 abstracts from articles that reference
human genes are available through PubMed [23]. Additional
valuable information can be seamlessly gained by including more
than 100,000 references from orthologous genes; many important
pathways have been more thoroughly explored in model systems
than in humans.
We have developed a novel statistical method to evaluate the
degree of relatedness among genes within disease regions: Gene
Relationships Among Implicated Loci (GRAIL). Given only a collection
of disease regions, GRAIL uses our text-based definition of
relatedness (or alternative metrics of relatedness) to identify a
subset of genes, more highly related than by chance; it also assigns
a select set of keywords that suggest putative biological pathways.
It uses no information about the phenotype, such as known
pathways or genes, and is therefore not tethered to potentially
biased pre-existing concepts about the disease.
In addition to a flexible text-based metric of relatedness,
GRAIL’s ability to successfully connect genes also leverages a
statistical framework that carefully accounts for differential gene
content across regions. We assume that each region contains a
single pathogenic gene; therefore narrow regions with one or just a
few genes are more informative than expansive regions with many
genes, since they are likely to have many irrelevant genes. To take
advantage of this, we have designed GRAIL to set a lower
threshold in considering relatedness for those genes in narrow
regions, allowing for more distant relationships to be considered;
on the other hand it sets a more stringent threshold for genes
located in expansive mutligenic regions and considers only the
very closest of relationships. This strategy prevents large regions
with many genes from dominating the analysis.
In this paper we apply GRAIL to four phenotypes. In each case
GRAIL is able to identify a subsets of genes enriched for
relatedness – more than expected by random chance. We
demonstrate enrichment for relatedness among true disease
regions rigorously based on both GRAIL’s theoretically derived
p-value and also based on parallel analysis of either (1) carefully
selected random regions matched for gene content and size or (2)
experimentally derived false positive disease regions.
GRAIL is able to identify subsets of highly related genes among
validated SNP associations. First we use GRAIL to identify related
genes from SNPs associated with serum lipid levels; GRAIL
correctly identifies genes already known to influence lipid levels
within the cholesterol biosynthesis pathway. In comparison to
randomly selected matched SNP sets, the set of lipid SNPs
demonstrate significantly more relatedness. Second, we use
GRAIL to identify significantly related genes near height-
associated SNPs; these genes highlight plausible pathways involved
in height. In comparison to randomly selected matched SNP sets,
the set of height SNPs also demonstrate significantly more
relatedness.
Encouraged by GRAIL’s ability to recognize biologically
meaningful connections, we tested its ability to distinguish true
disease regions from false positive regions in two practical
applications in human genetics. First, in Crohn’s disease, we start
with a long list of putative SNP associations from a recent GWA
(genome-wide association) meta-analysis [24]. We demonstrate
that a substantial fraction of these SNPs contain highly related
genes—far beyond what can be expected by chance. We
demonstrate that many of these SNPs subsequently validate in
an independent replication genotyping experiment. Second, in
schizophrenia, we previously identified an over-representation of
rare deletions in schizophrenia cases compared to controls [8].
Despite the statistical excess, it is challenging to identify exactly
which case deletions are causal, given the relatively high
background rate of rare deletions in controls. Using GRAIL
however, we are able to demonstrate that a subset of case deletions
contain related genes. We further demonstrate that these genes are
highly and significantly enriched for central nervous system (CNS)
expressed genes. In stark contrast, GRAIL finds no excess
relatedness among genes implicated by case deletions.
Results
Summary of statistical approach
GRAIL relies on two key methods: (1) a novel statistical
framework that assesses the significance of relatedness between
genes in disease regions (2) a text-based similarity measure that
scores two genes for relatedness to each other based on text in
PubMed abstracts. Details for both are presented in the Methods.
The GRAIL statistical framework consists of four steps (see
Figure 1). First, given a set of disease regions we identify the genes
overlapping them (Figure 1A); for SNPs we use LD (linkage
disequilibrium) characteristics to define the region. Second, for
Author Summary
Modern genetic studies, including genome-wide surveys
for disease-associated loci and copy number variation,
provide a list of critical genomic regions that play an
important role in predisposition to disease. Using these
regions to understand disease pathogenesis requires the
ability to first distinguish causal genes from other nearby
genes spuriously contained within these regions. To do
this we must identify the key pathways suggested by
those causal genes. In this manuscript we describe a
statistical approach, Gene Relationships Across Implicated
Loci (GRAIL), to achieve this task. It starts with genomic
regions and identifies related subsets of genes involved in
similar biological processes—these genes highlight the
likely causal genes and the key pathways. GRAIL uses
abstracts from the entirety of the published scientific
literature about the genes to look for potential relation-
ships between genes. We apply GRAIL to four very
different phenotypes. In each case we identify a subset
of highly related genes; in cases where false positive
regions are present, GRAIL is able to separate out likely
true positives. GRAIL therefore offers the potential to
translate disease genomic regions from unbiased genomic
surveys into the key processes that may be critical to the
disease.
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each overlapping gene we score all other human genes by their
relatedness to it (Figure 1B). In this paper we use a text-based
similarity measure; alternative measures of relatedness, for
example similarity in gene annotations or expression data, could
be easily applied instead [25,26]. Third, for each gene we count
the number of independent regions with at least one highly related
gene (Figure 1C); here the threshold for relatedness varies between
regions depending on the number of genes within them. We assign
a p-value to that count. Fourth, for each disease region we select
the single most connected gene as the key gene. We assign the
disease region that key gene’s p-value after adjusting for multiple
hypothesis testing (if there are multiple genes within the region)
(Figure 1D). This final score is listed in this paper as pmetric where
the metric is text, expression, or annotation based. Very low ptext scores
for one region indicate that a gene within it is more related to
genes in other disease regions through PubMed abstracts than
Figure 1. Gene Relationships Among Implicated Loci (GRAIL) method consists of four steps. (A) Identifying genes in disease regions. For
each independent associated SNP or CNV from a GWA study, GRAIL defines a disease region; then GRAIL identifies genes overlapping the region. In
this region there are three genes. We use gene 1 (pink arrow) as an example. (B) Assess relatedness to other human genes. GRAIL scores each gene
contained in a disease region for relatedness to all other human genes. GRAIL determines gene relatedness by looking at words in gene references;
related genes are defined as those whose abstract references use similar words. Here gene 1 has word counts that are highly similar to gene A but not
to gene B. All human genes are ranked according to text-based similarity (green bar), and the most similar genes are considered related. (C) Counting
regions with similar genes. For each gene in a disease region, GRAIL assesses whether other independent disease regions contain highly significant
genes. GRAIL assigns a significance score to the count. In this illustration gene 1 is similar to genes in three of the regions (green arrows), including
gene A. (D) Assigning a significance score to a disease region. After all of the genes within a region are scored, GRAIL identifies the most significant
gene as the likely candidate. GRAIL corrects its significance score for multiple hypothesis testing (by adjusting for the number of genes in the region),
to assign a significance score to the region.
doi:10.1371/journal.pgen.1000534.g001
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expected by chance. Simulations on random groups of SNPs
demonstrate that the ptext values approximately estimate Type I
error rates, being approximately uniformly distributed under the
null hypothesis (see Figure S1). However, we recommend the use
of careful simulations or controls rather than actual theoretical p-
values to reinforce the significance of GRAIL’s findings – as we do
in the examples below.
The text-based similarity metric is based on standard approach-
es used in statistical text mining. To avoid publications that report
on or are influenced by disease regions discovered in the recent
scans, we use only those PubMed abstracts published prior to
December 2006, before the recent onslaught of GWA papers
identifying novel associations. This approach effectively avoids the
evaluation of gene relationships being confounded by papers
listing genes in regions discovered as associated to these
phenotypes. In addition to including primary abstract references
about genes listed in Entrez Gene, we augment our text
compendium with references to orthologous genes listed in
Homologene [23]; this increases the number of articles available
per gene from 6 to 12 (see Table 1). We note that the distribution
of articles per gene is skewed toward a small number of genes with
many references; 0.4% of genes are referenced by .500 articles,
while 26% of genes are referenced by ,5. In fact 2,034 genes
could not be connected to any abstracts at all. For each abstract we
convert free text into vectors of word counts [19]. For each gene
we define a word vector that consists of averaged word counts
from document references to it. Pairwise gene relatedness is then
the correlation between the vectors of word counts between two
genes. Two genes that are referenced by abstracts using the same
sorts of words will receive a high similarity score, whereas two
genes that have abstract references that largely use a different
vocabulary will receive a low score (Figure 1B). Importantly, genes
do not need to be co-cited in the same document to be identified as
highly similar.
After regions are scored with GRAIL, PubMed text can be used
to identify keywords that may provide insight into the underlying
biological pathways. We define these keywords as those words that
most strongly link the significant genes in each region, that is the
words with overall greatest weight across all of the text vectors
from those genes.
Since the GRAIL framework can be easily used with any gene
relatedness metric, we also devised and tested two alternative
metrics derived from Gene Ontology (GO) annotations [27] and
an mRNA expression atlas consisting of expression measurements
across multiple human tissues (The Novartis Gene Expression
Atlas) [28]. These metrics are described in greater detail in
Methods.
Evaluating relationships between known associated
SNPs: lipid levels and height
We first applied GRAIL to a set of 19 validated SNPs associated
with triglyceride, LDL, and/or HDL levels [5,6]. Since 14 SNPs (out
of 19) are near genes that are known members of lipid metabolism
pathways, we hypothesized that GRAIL should be able to identify
these genes accurately. A total of 87 genes were implicated by the 19
associated SNPs. Of the 14 SNPs near compelling candidate genes,
13 obtained ptext scores,0.01 (Figure 2A, Table S1). GRAIL correctly
identified those genes implicated in lipid metabolism from each of
these 14 regions. To asses the significance of these findings, we
applied GRAIL to 1000 random matched SNP sets; each set
consisted of 19 SNPs randomly selected from a commercial
genotyping array which implicated a similar total of 87610 genes.
In contrast to lipid associated SNPs, not a single matched random set
contained 13 SNPs that obtained ptext scores#0.01; on average
matched sets had 0.26 (maximum 6) SNPs with ptext#0.01 (Figure 2A).
Thus, there is substantial enrichment for highly connected genes
captured by true lipid associated SNPs.
Despite relatively comprehensive lipid biology annotation, GO
does not identify relationships between regions as effectively as
published text (Figure 2A). A total of 12 out of the 19 associated
SNPs obtained pannotation,0.01. Relationships between highest
scoring candidate genes are explained by several shared GO
codes including: GO:0008203 (‘cholesterol metabolic process’),
GO:0016125 (‘sterol metabolic process’), GO:0006629 (‘lipid
metabolic process’), GO:0008202 (‘steroid metabolism’), and
GO:0005319 (‘lipid transporter activity’). Gene expression does
not identify relationships between regions as effectively as text,
either (Figure 2A). A subset of 4 associated SNPs obtain
pexpression,0.01. The regions with the most significantly connected
genes have similar tissue-specific expression profiles. The highest
expression is in four samples taken from adult and fetal liver
tissues, known to play a major role in cholesterol metabolism.
While associated SNPs are less connected with these alternative
metrics, they do seem to leverage the appropriate functional
variables and provide valuable phenotypic information.
We next applied GRAIL to 42 validated SNP associations to
adult height in recent GWA studies [2–4]. This application tests
GRAIL’s ability to connect genes in the absence of functional
literature connecting the phenotype to the relevant pathways. In
contrast to lipid metabolism, all associated common SNPs were
identified in 2007 and 2008 and the underlying biological
pathways involved in height are still poorly understood. This
insures independence between association results and the
functional literature from before 2007 that is mined in this study.
In most cases the key genes are not yet known.
Table 1. Text resources.
Refs/gene
Genes Articles References mean median mean median
Standard 18,690 137,395 260,658 13.9 6 1.9 1
Homologs 15,990 138,720 434,690 27.1 13 3.1 1
Combined 18,875 259,638 599,537 31.7 12 2.3 1
We obtained text from abstracts relevant to human genes from PubMed on December 2006. In the first row we list the number of human genes with any references
listed, the total number of abstracts referencing them, and the total number of gene references. We then list the mean and median number of abstract references per
gene, and also the mean and median number of gene references per abstract. We used Homologene to identify human gene orthologs, and obtained text for those
genes; information about those genes and references is listed in the second row. We combined the two pools of gene references to create a large combined database
of 18,875 genes with 599,537 references to 259,638 articles, described in the third row.
doi:10.1371/journal.pgen.1000534.t001
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The 42 height SNPs implicated a total of 185 genes (Table S2).
Of these 42 regions, 13 obtained ptext scores,0.01 (Figure 2B). For
comparison, we used GRAIL to score 1000 matched SNP sets; as
before each set consisted of 42 SNPs randomly selected from a
commercial array and implicated a total of 185610 genes. Not a
single random set contained 13 SNPs that obtained ptext
scores#0.01; on average matched sets had 0.77 (maximum 10)
SNPs with ptext scores,0.01. Thus, we present clear statistical
evidence that GRAIL identifies genes with non-random functional
connections among associated loci.
Strikingly, the top five keywords linking the genes were
‘hedgehog’, ‘histone’, ‘bone’, ‘cartilage’, and ‘growth’ (see Table
S3 for a more complete list). Of note, ‘height’, does not emerge as
a keyword since these genes had not been previously related to
height. For comparison, the top five keywords for lipid metabolism
associated SNPs were ‘lipoprotein’, ‘cholesterol’, ‘lipase’, ‘apoli-
poprotein’, and ‘triglyceride’ (Table S3). These results are
particularly noteworthy as this analysis uses only a simple list of
SNPs implicated by GWA studies—no specific biological pathways
or mechanisms or phenotype details are assumed.
Genetic associations to Crohn’s disease and
schizophrenia—predicting disease regions
After successfully applying GRAIL to validated associations for
two phenotypes, we hypothesized that GRAIL could also be used
to prospectively identify true disease regions, based on the
relatedness of genes within them, from false positive regions. We
tested GRAIL’s ability to distinguish disease regions from a longer
list of results containing a large number of false positive regions as
well in two separate human genetics applications.
A recent GWA meta-analysis in Crohn’s disease identified 74
independent SNPs as nominally significant (p,561025) [24].
While the excess beyond chance suggested many of these regions
were likely true positives, up to half of these regions should by
necessity be unrelated to Crohn’s and simply represent the tail of
the null distribution. Thus we sought to explore whether GRAIL
could identify a subset of these SNPs that implicate an inter-
connected set of genes, and whether those represented true
associations that could be validated.
In a now published replication genotyping of the 74 SNPs, 30
replicated convincingly when tested in independent samples
(defined as having one-tailed association p-values,0.0007 in
replication samples and two tailed association p-values,561028
overall), confirming true positive associations, whereas 22
convincingly failed to replicate (defined as overall association p-
value rising to .1024); the remaining 22 regions had intermediate
levels of significance following replication (and can be considered
as yet unresolved associations) [24].
We applied GRAIL prospectively to these 74 nominally
associated SNPs. GRAIL was initially operated independent of
Figure 2. SNPs associated with lipid metabolism and height contain genes related to each other. (A) 19 SNPs associated with lipid
metabolism. The y-axis plots the ptext values on a log scale, with increasing significance at the top. The histogram on the left side of the graph
illustrates values for matched SNP sets. 88.6% of those SNPs have ptext values that are .0.1. The scatter plot on the right illustrates ptext values for
actual serum cholesterol associated SNPs (blue dots). Black horizontal line marks the median ptext value. We assessed the same SNP with similarity
metrics based on gene annotation (green dots) and gene expression correlation (purple dots). (B) 42 SNPs associated with height. Similar plot for 42
height associated SNPs. The histogram on the left of the graph illustrates ptext values for random SNP sets carefully matched to height-associated SNP
set. 86.5% of those SNPs have ptext values that are .0.1. The scatter plot on the right illustrates ptext values for actual SNPs associated with height
(blue dots). Black horizontal line marks the median ptext value. We assessed the same SNP with similarity metrics based on gene annotation (green
dots) and gene expression correlation (purple dots). On the right we list for each ptext threshold the number of expected SNPs less than the threshold
based on matched sets, and the number of observed SNPs less than the threshold among height associated SNPs.
doi:10.1371/journal.pgen.1000534.g002
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any knowledge of the contemporaneous replication genotyping
experiment. Each region contained between 1 and 34 genes,
except for two regions that contained no genes and were not
scored. GRAIL identified 13 regions as significant (achieving ptext
scores,0.01), as with the previous examples far in excess of
chance.
Of those 13 regions, 10 were among the set that convincingly
validated in subsequent replication (Table 2)—the remaining three
had indeterminate levels of significance. By contrast, only 20 of 63
SNPs remaining SNPs validated (Table S4). Disease regions that
replicate have more significant GRAIL scores than those that
failed (p= 0.00064, one-tailed rank-sum test, Figure 3A). As with
randomly selected SNP lists, the distribution of scores for the 21
failed regions was indistinguishable from a random (uniform)
distribution of p-values (Figure 3B).
Using these Crohn’s results, we have compared GRAIL’s
performance to four other competing algorithms that also use
functional information to prioritize genes, and GRAIL’s perfor-
mance is superior at predicting true positive associations (see Text
S1, Figure S2, Table S5, Table S6).
As a further test of GRAIL, we then evaluated the next most
significant 74 associated SNPs that emerged from the Crohn’s
disease GWA meta-analysis (association p-values ranging from
561025 to 261024). Out of the 75 regions, 8 are not near any
gene, and we did not score them. The remaining 67 regions were
tested with GRAIL for relationships to the 52 replicated and
indeterminate regions that emerged following replication. Two
emerge with highly significant GRAIL scores: rs8178556 on
chromosome 21 (IFNAR1, ptext = 1.7610
24) and rs12928822 on
chromosome 16 (SOCS1, ptext = 8.2610
24) suggesting these inde-
pendent regions may lead to novel associated SNPs for Crohn’s
disease (see Table S7).
We next applied GRAIL to recently published sets of rare
deletions seen in schizophrenia cases and matched controls.
Multiple groups have recently demonstrated that extremely rare
deletions, many of which are likely de novo, are notably enriched
in schizophrenia [8–10,29]. However, since rare deletions occur
frequently in healthy individuals as well, many of these case
deletions will also be non-pathogenic. In fact, we previously found
that large (.100 kb), gene overlapping, singleton, deletions were
present in 4.9% of cases but also in 3.8% of controls, suggesting
that over two-thirds of these deletions are not relevant to disease
[8]. We identified 165 published de-novo or case-only deletions of
.100 kb overlapping at least one gene; a total of 511 genes are
deleted or disrupted by these deletions [8,9,10]. Additionally, we
identified 122 regions similar control-only deletions; a total of 252
genes are deleted or disrupted by these deletions.
We applied GRAIL separately to both the case and control sets
of deletions. In the case deletions, we identified a subset containing
highly connected genes (Figure 4A). Specifically, 12 of the 165
regions obtain ptext scores,0.001 with text-similarity (Table 3). The
top keywords suggest some common biological underlying
functions: ‘phosphatase’, ‘glutamate’, ‘receptor’, ‘cadherin’, and
‘neurons’. In contast, we did not identify any regions with
significantly related genes in the corresponding list of deletions; out
of a total 124 regions, none obtained ptext scores,0.001 (see Table
S8). This represents a significant enrichment within the cases
(p= 0.01, one Fisher’s exact text).
We then sought independent assessment of the biological
relationship of the genes highlighted by GRAIL by examining the
extent to which these genes demonstrate preferential expression in
CNS tissues using a publicly available tissue atlas [30]. Here we
define preferential expression as median CNS tissue expression
significantly greater than in other tissues (p,0.01 by one-tailed
Table 2. High scoring regions from a Crohn’s disease GWA meta-analysis.
SNP Chr Position (HG17) passociation Replication Study Result N (genes) Implicated Gene ptext
rs2066845 16 49314041 1.5E-24 VALIDATED 3 NOD2 0.00010
rs10863202 16 84545499 1.4E-05 INDETERMINATE 4 IRF8 0.00058
rs10045431 5 158747111 1.9E-13 VALIDATED-NOVEL 1 IL12B 0.00066
rs11465804 1 67414547 3.3E-63 VALIDATED 1 IL23R 0.00094
rs2476601 1 114089610 7.3E-09 VALIDATED-NOVEL 8 PTPN22 0.0014
rs762421 21 44439989 7.0E-10 VALIDATED-NOVEL 1 ICOSLG 0.0023
rs2188962 5 131798704 1.2E-18 VALIDATED 9 IRF1 0.0026
rs917997 2 102529086 1.1E-05 INDETERMINATE 5 IL18RAP 0.0027
rs11747270 5 150239060 1.7E-16 VALIDATED 3 IRGM 0.0032
rs2738758 20 61820069 2.7E-06 INDETERMINATE 10 TNFRSF6B 0.0038
rs9286879 1 169593891 7.7E-10 VALIDATED-NOVEL 4 TNFSF18 0.0042
rs2301436 6 167408399 5.2E-13 VALIDATED-NOVEL 3 CCR6 0.0052
rs4263839 9 114645994 1.3E-10 VALIDATED 2 TNFSF8 0.008
rs3828309 2 233962410 1.2E-32 VALIDATED 4 USP40 0.019
rs744166 17 37767727 3.4E-12 VALIDATED-NOVEL 2 STAT3 0.023
rs7758080 6 149618772 4.4E-06 INDETERMINATE 4 SUMO4 0.033
rs7161377 14 75071147 2.3E-05 INDETERMINATE 1 BATF 0.09
Here we list a subset of the 74 regions that emerged from a Crohn’s disease GWA meta-analysis that GRAIL assigned the most compelling ptext scores to. The first three
columns list information about the associated SNP. The fourth column lists the combined p-value of association from a GWA meta-analysis and subsequent replication.
The fifth column indicates whether the region was validated, indeterminate, or failed in replication. Those regions that represent novel findings, not previously
published are also indicated. The sixth column lists the number of genes in the disease region, and the seventh column lists the candidate gene identified by GRAIL. The
eighth column lists the regions ptext score.
doi:10.1371/journal.pgen.1000534.t002
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rank-sum test). Considering the entire set, case-deletions are not
enriched for genes preferentially expressed in the CNS (22% are
preferentially expressed in the CNS, compared to 25% of control-
deletion genes). However, considering the subset of genes
indentified by GRAIL (ptext,0.01), 60% (9 of 15 genes) are
preferentially CNS expressed. Furthermore, the fraction of genes
with preferential CNS expression correlates inversely with the
significance of the GRAIL score (Figure 4B). Regions that GRAIL
assigns non-significant scores to, do not demonstrate any
compelling enrichment for CNS expressed genes.
Discussion
We have presented an automated text-based strategy to take a
list of disease regions and identify those regions with significantly
inter-related genes. In the process it recognizes the likely candidate
gene in each disease region. It makes no assumptions about the
phenotype being studied or underlying pathways that might be
presumed to be relevant to a disease state. While in principle a
diligent investigator could potentially examine the literature
related to all potentially associated genes and arrive at the same
conclusions, they are unlikely in practice be able to work with the
same efficiency and objectivity as the approach outlined here. In
the schizophrenia application, for example, we objectively
interpret and analyze the relationship between over 500 genes.
We present data that GRAIL can identify common SNPs that
subsequently validate in replication genotyping. We have demon-
strated superior performance in this application to other methods.
This approach could have widespread application to follow-up
GWA study results and offers a mechanism to prioritize the
hundreds of SNPs that are expected to achieve an intermediately
significant level of association (1025,p,1023). As far as we are
aware – this is the first successful prediction of the outcome of a
GWA validation study.
GRAIL offers the greatest value in situations where disease
regions are being considered that are difficult to validate, for
example rare deletions. The ability to genetically validate any
individual rare deletion is challenged given the limited power
afforded by the size of available patient collections. In schizo-
phrenia the excess of rare deletions has now been well documented
– but it had been difficult to connect these rare deletions to a
specific pathway. We identified a subset of related genes that have
functions that are plausibly related to schizophrenia. As other
diseases emerge where rare variants play a role in the genetic
architecture, our approach may provide a crucial first step to put
context to genetic findings.
Connecting seemingly unrelated genes through text
The main strength of GRAIL is its ability to link genes through
text that may not yet have an established common pathway or
process. Consider the IRGM gene association to Crohn’s disease –
for which GRAIL found strong evidence (uncorrected
ptext = 0.0011). GRAIL’s text-based similarity metric recognize
the significant connections between IRGM and four other
validated or intermediate region genes: IRF1, IL12B, IRF8, and
Figure 3. GRAIL predicts Crohn’s disease SNPs. (A) Validated versus Failed SNPs. Prior to replication, GRAIL scored Crohn’s SNPs that emerged
from a meta-analysis study. Results from follow-up testing either validated Crohn’s SNPs, or identified those SNPs that failed. We produce a scatter
plot of the significance of text-based similiarty (ptext) for validated regions (green) versus regions that failed to replicate (red). Black horizontal lines
mark the median ptext values. The distribution of scores for failed SNPs resembles a random distribution of p-values. The distribution of scores for
validated SNPs is significantly different; almost K of these SNPs obtain ptext scores,0.1. (B) Histogram of text-based scores for Crohn’s disease
candidate regions. Here we plot a histogram of ptext scores for 74 Crohn’s disease SNPs. Validated SNPs (green) have ptext values that are enriched for
significant values. Indeterminate SNPs (yellow) have a subset of ptext values that are significant. Failed SNPs (Red) have all of their ptext scores.0.1.
doi:10.1371/journal.pgen.1000534.g003
Identifying Common Function Across Disease Regions
PLoS Genetics | www.plosgenetics.org 7 June 2009 | Volume 5 | Issue 6 | e1000534
SP110. IRGM is not readily connected to these genes in a well-
defined pathway and, in-fact, is not referenced together with them
in any abstracts; furthermore no IRGM interactions are listed in
Entrez at all. Yet they all are involved in the host response to
Mycobacterium and possibly other intracellular infections by
macrophages. The top keywords describing the connections
between IRGM and these genes were ‘macrophages’, ‘tuberculosis’
and ‘mycobacterium’. The IRGM gene has been shown exper-
imentally to eliminate intracellular Mycobacterium tuberculosis via
autophagy [31]. The IRF1 homolog studies in mouse have
demonstrated its role in intra-cellular nitrous oxide production,
necessary to fight Mycobacterium infections [32]. Individuals with
loss of function IL12B mutations have been found with increased
susceptibility to Mycobacterium infections [33] and knock out mice
have demonstrated increased susceptibility to infection [34,35]. A
SP110 mouse homolog has been shown to mediate innate
immunity in fighting intra-cellular Mycobacterium tuberculosis infec-
tion [36]. GRAIL is able to identify this common underlying
similarity between these genes, and assign a significant score to
IRGM, while at the same time revealing what may be an important
pathway in Inflammatory Bowel Disease. Other strategies
depending on interaction networks or functional databases may
struggle to detect these relationships.
Identifying disease genes within a region
GRAIL systematically identifies a single gene within a disease
region as the likely disease gene. We highlight two interesting
examples from the height data of previously unrecognized
potentially causative genes. The first example is the rs42046
SNP on chromosome 7 region implicating five genes. The genetic
studies that identified this region had suggested CDK6 as the likely
causative gene [2–4]. However, GRAIL found greatest evidence in
support of PEX1 (uncorrected ptext = 0.0084). When we compare
the most compelling of these genes, PEX1, to candidates from the
other 41 SNPs with our text-based metric, we found it to be most
related to a gene in a height-associated SNP on chromosome 8,
PEX2 (PXMP3). The protein products of both PEX1 and PEX2 are
involved in peroxisome biogenesis and are implicated in a genetic
disease associated craniofacial and skeletal abnormalities (Zellwe-
ger’s syndrome) [37–39]. While it may be a coincidence that these
two closely related genes are associated by chance, it is certainly
possible that peroxisome biogenesis represents a previously
unrecognized height pathway. The second example is the
rs10935120 SNP on chromosome 3, implicating three genes; the
genetic study that had identified this gene had suggested ANAPC13
as the likely candidate in the region [4]. However, GRAIL
identified the KY gene as the most likely disease gene (ptext = 0.04).
Figure 4. GRAIL identifies a subset of highly connected genes within rare deletions found in Schizophrenia cases. (A) Case deletions
versus control deletions. Here we plot the results of the separate GRAIL analyses conducted on the deletions observed in schizophrenia cases and
controls. Case deletion ptext scores are displayed in red; control deletion ptext scores are displayed in green. The line in each category in the middle of the
box represents the median GRAIL ptext score. The box represents the 25–75% range. The bars represent the 5–95% range. Additional scores outside the
range are individual plotted. (B) Text-based GRAIL significance score tracks with CNS specific expression. We partition case-only deletions by their GRAIL
scores. For each range of GRAIL ptext scores, we assess the candidate genes selected by GRAIL for CNS expression. The upper portion of this plot
illustrates the fraction of those candidate genes that demonstrate preferential CNS expression along with 95% confidence intervals. The blue line
represents the total fraction of genes that are preferentially CNS expressed. For the most compelling GRAIL scores, the candidate genes are significantly
enriched for CNS expression compared to what would be expected from a random group of genes. The lower portion of the plot is a histogram.
doi:10.1371/journal.pgen.1000534.g004
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In fact, a mutation in the KY gene causes spinal scoliosis in a
mouse model [40], and the KY protein product interacts with
sarcomeric cytoskeletal proteins [41]. While these literature-based
hypotheses may be obvious to a few specialized researchers, the
strength of GRAIL is that it is able to suggest these connections in
a systematic and objective manner from the entirety of the
published literature.
Genes deleted in schizophrenia suggest relevant
neuronal processes
We consider closely the subset of related genes identified by
GRAIL from rare deletions in patients with schizophrenia.
Schizophrenia is a disorder characterized by hallucinations,
delusions, cognitive deficits and apathy. The molecular basis of
the symptom complex associated with the disorder is largely
unknown. However accumulating evidence suggest that dysregu-
lation of synaptic activity and abnormalities in neuronal
development and migration may contribute to the pathophysiol-
ogy of schizophrenia [42]. Many of the highest scoring genes
recovered by GRAIL within the deleted regions in cases (Table 3)
are localized to the postsynaptic membrane/signaling complex
that propagate signals resulting in changes synapse function and
downstream gene expression/transcription. The DLG2 gene
product interacts at postsynaptic sites to form a multi-meric
scaffold for the clustering of receptors, ion channels, and
associated signaling proteins. MAGI1 and MAGI2 both encode
post-synaptic scaffolding molecules involved in cell adhesion and
signaling [43,44]. Furthermore, glutamatergic neurotransmission
is implicated through the selection of GRM1, GRM7, and GRM8.
Many of the most significant candidate genes identified by GRAIL
are involved in neuronal development, cell-cell adhesion and axon
guidance. CNTN5 is an immunoglobulin super-family membrane-
anchored neuronal protein that is also an adhesion molecule [45].
It may play a role in the developing nervous system [46]. The
SDK1 gene expresses a synaptic adhesion protein [47] that guides
axonal terminals to specific synapses in developing neurons. The
PTPRM encodes a neuronally expressed protein tyrosine phos-
phatase that mediates cell-cell aggregation and is involved in cell-
cell adhesion [48,49].
Competing methods
The most critical technical difference between GRAIL and
other strategies is that it does not use any strict definitions of gene
functions or interactions, but rather uses a metric of relatedness
that allows for a relatively broad range of freedom with which to
connect genes. While GRAIL will certainly identify relationships
between genes known to be in a common pathway, it goes beyond
that, and can allow less strict evidence. In fact, it is even able to
identify relatedness between genes that have no established
common pathways or article co-citations! In contrast, other
strategies start with static gene relationships—such as (1) pre-
constructed molecular networks [12,16] or sets of gene with
common function [11,15] or (2) a subset of functions identified as
relevant to disease either by the user [17] or by mining the
published text [14]. In a head to head match up against four other
methods that we were able to obtain implemented versions of,
GRAIL demonstrated superior performance in predicting Crohn’s
associated SNPs (see Text S1, Figure S2, Table S5, and Table S6).
Limitations to assessing gene relatedness with text
While we have shown the promise of text-based similarity in
identifying regions and the genes within them that are part of a
larger biological pathway, we note that this strategy’s effectiveness
is wholly contingent on the completeness of the scientific text. It
could be biased towards subsets of genes and pathways that are
particularly well studied, and against poorly studied ones. In many
of the cases that we illustrate, there are regions that could not be
connected – for example, GRAIL fails to connect 5 validated
Crohn’s SNPs that obtain ptext scores.0.5 (Figure 3B). These
regions might have been missed since the relevant gene is either
poorly studied, or even if the gene is well studied, the relevant
function of that gene is not well documented in the text. An
alternative possibility is that the SNP is tagging non-genic
regulatory elements. Additionally, the SNP may be the first
discovered representative association for a critical pathway, not
represented by other SNP associations – and therefore cannot be
connected to them. In this case future discoveries will clarify the
significance of that association.
In cases where there is no apparent published connection
between associated genes, other similarity metrics based on
experimentally derived data, such as gene expression, protein-
Table 3. Rare or de novo schizophrenia case deletions.
CHR Start Stop ptext Candidate Gene
7 77,788,564 78,591,795 0.0000013 MAGI2
11 *83,680,969 83,943,977 0.0000016 DLG2
3 65,781,878 65,975,330 0.0000057 MAGI1
11 99,153,400 99,286,239 0.000013 CNTN5
4 *87,919,851 88,032,640 0.000025 PTPN13
18 8,054,730 8,257,748 0.000035 PTPRM
3 *7,177,597 7,314,117 0.000087 GRM7
3 7,043,889 7,145,741 0.000087 GRM7
6 146,418,079 146,525,433 0.00013 GRM1
7 125,707,286 126,050,230 0.00015 GRM8
9 9,485,226 9,644,834 0.00024 PTPRD
7 3,759,288 4,087,229 0.00033 SDK1
3 *197,224,662 198,573,215 0.0011 DLG1
15 27,015,263 28,173,703 0.0014 TJP1
5 31,250,352 32,213,541 0.0033 PDZD2
19 10,231,490 10,493,592 0.0048 ICAM5
2 112,407,513 112,512,196 0.014 MERTK
5 19,570,562 19,843,415 0.018 CDH18
6 145,876,484 146,009,981 0.019 EPM2A
7 145,321,439 145,461,533 0.019 CNTNAP2
5 63,115,468 63,431,545 0.023 HTR1A
14 66,287,336 66,470,393 0.025 GPHN
18 56,109,430 56,255,536 0.029 MC4R
5 106,805,717 107,026,020 0.03 EFNA5
2 233,029,864 233,134,571 0.031 ALPPL2
20 2,923,491 3,618,945 0.034 PTPRA
1 72,287,807 72,439,333 0.037 NEGR1
7 94,306,868 94,497,412 0.044 PPP1R9A
7 157,378,450 157,569,847 0.046 PTPRN2
1 *144,943,150 146,292,286 0.047 ACP6
Here we list all of the deletions that GRAIL identified as most related to other
deleted genes (ptext,0.05). For each deletion we list the chromosome, the
range of the deletion, the GRAIL p-value for the region, and the best candidate
gene in the region identified by GRAIL. Most genomic coordinates are listed in
HG17. *HG18 coordinates.
doi:10.1371/journal.pgen.1000534.t003
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protein interactions and transcription factor binding sites could
also complement the text-based approaches presented here. In
fact, we demonstrate how annotation-based metrics or gene
expression-based metrics are able to identify a subset of the
associated SNPs in lipid metabolism. As these and other metrics
are optimized, they could be used in conjunction with the novel
GRAIL statistical framework that we present here to help
understand gene relationships.
Methods
Scoring regions for functional relatedness
The Gene Relationships Among Implicated Loci (GRAIL) has
four basic steps that are outlined below. It has two input sets of
disease regions: (1) a collection of NSEED seed regions (SNPs or
CNVs) and (2) a collection of NQUERY query regions. Genes in query
regions are evaluated for relationships to genes in seed regions, and
query regions are then assigned a significance score. In most
applications we are examining a set of regions for relationships
between implicated genes, the query regions and the seed regions are
identical. In other circumstances where we have a set of putative
regions that are being tested against validated ones, the putative
regions are defined as query regions, and the validated ones are
defined as seed regions.
Step 1. Defining disease regions and identifying
overlapping genes. For each query and seed SNP we find the
furthest neighboring SNPs in the 39 and 59 direction in LD
(r2.0.5, CEU HapMap [50]). We then proceed outwards in each
direction to the nearest recombination hotspot [51]. The interval
between those two hotspots, which would include the SNP of
interest and all SNPs in LD, is defined as the disease region. The
associated SNP could feasibly be tagging a stronger SNP signal
from another SNP in that region. All genes that overlap that
interval are considered implicated by the SNP. If there are no
genes in that region, the interval is extended an additional 250 kb
in either direction; we chose 250 kb as that distance since that is a
range in which non-coding variants might express gene regulation
[52]. For each query and seed CNV we define an interval that
represents the deleted or duplicated region—all genes that overlap
that interval are associated with the CNV for testing.
Step 2. Ranking gene relatedness. For each gene near a
query region, we rank all human genes for relatedness. Ranking
may be based on text similarity, or other metrics (see below for
examples). Rank values range from 1 (most related) to NG (least
related), where NG is the number of available human genes, in our
application is 18,875 (see Table 1).
Step 3. Scoring candidate genes against regions. To
avoid double counting nearby regions, we first combine any seed
regions sharing one or more genes. For a given gene g in a query
region, we examine the degree of similarity to any of the ns genes
in a given seed region s. To ensure independence, we only look at a
seed region s, if it does not share a single gene with the query region
that gene g is contained in.
We identify in each region s, the rank of the most similar (or
lowest ranking) gene in it to gene g, Rg,s. We convert the rank to a
proportion:
pg,s,uncorrected~Rg,s

NG
To transform this proportion to a uniformly distributed entity
under the null, we recognize that Rg,s was the lowest rank selected
from ns genes – and we correct accordingly for multiple hypothesis
testing:
pg,s~1{ 1{pg,s,uncorrected
 ns
Now we identify those seed regions where pg,s is less than a pre-
specified threshold pf as regions connected to gene g. For all
applications presented here pf is arbitrarily set to 0.1. The number
of seed regions containing at least one gene exceeding this
threshold, nhit, can be approximated under a random model with
a Poisson distribution.
We assign a greater weight to those cases where there is greater
similarity; that is in the cases where pg,s is particularly small:
wg,s~
{log
pg,s
pf
 
pg,sƒpf
0 pg,swpf
( )
Under a random model, if pg,s,pf , pg,s should range approximately
uniformly from 0 to pf. Therefore, under these circumstances wg,s
can be modeled approximately with a gamma distribution.
For each candidate gene, g, we tally the number of seed regions
that contain a highly related gene into a weighted count, cg:
cg~
X
i
wsi ,g~
X
pg,sivpf
{log
psi ,g
pf
 
After testing gene g across NSEED seed regions for related genes,
the probability of a score exceeding cg under the null, pg, can be
approximated:
pg~p cwcg
 
~
XNseed
nhit~0
p cwcg,nhit
 
~
XNseed
nhit~0
p nhitð Þp cwcg nhitj
 
Where nhit is the number of seed regions connected to gene g. Since
under the null model the probability of a connected region by
chance is always pf, we can estimate its probability distribution of
nhit with a Poisson distribution:
p nhitð Þ~
NSEEDpf
 nhit e{NSEEDpf
nhit!
Since, cg, is the sum of the log of nhit independent uniformly
distributed values ranging from 0 to 1, for a fixed value of nhit we
can calculate the distribution of cg with a cumulative gamma
distribution:
p cwcg nhitj
 
~FGamma ?,nhit,1ð Þ{FGamma cg,nhit,1
 
Since nhit is always an integer, the FGamma term can be simplified:
FGamma cg,nhit,1
 
~1{
Xnhit{1
i~0
cg
 i
i!
e{cg
Therefore, we can be further simplified:
p cwcg nhitj
 
~FGamma ?,nhit,1ð Þ{FGamma cg,nhit,1
 
~
Xnhit{1
i~0
cg
 i
i!
e{cg
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Putting this together:
pg~
XNseed
nhit~0
NSEEDpf
 nhit e{NSEEDpf
nhit!
Xnhit{1
i~0
cg
 i
i!
e{cg
 !" #
Step 4. Scoring regions. Finally, for each query region we
identify the best scoring gene within it. A significance score for the
query region, pq, is based on the p-value of that gene, pg, corrected
for multiple hypothesis testing. Assuming the region has nq genes
within it:
pq~1{ 1{pg
 nq where pg~min pg’ g’ [ qj 
Assessing gene relatedness with text-based similarity
We measure relatedness between genes using similarity in
published text from gene references. We first obtain article
abstracts from Pubmed. We downloaded all abstracts on
December 16, 2006. For each gene, we identified and downloaded
abstract references listed in Entrez Gene [23]; additionally, we
downloaded Entrez Gene abstract references for gene orthologs
listed in Homologene [53]. We removed those articles referencing
more than 10,000 genes. Only the title (TI) and abstract (AB) fields
were included for further text processing. We defined a vocabulary
consisting of only those terms appearing in 40 or more abstracts,
and fewer than 130,000; this resulted in a vocabulary of 23,594
terms. For each abstract j we create a vector of term frequencies,
tfij, representing the number of times each term i appears within it.
Term frequencies are transformed into weights, wij, according to a
standard inverse document frequency scheme [54]:
wij~
1zlog tfij
  	
log2
NDOC
dfi
 
tfijw0
0 tfij~0
( )
where NDOC is the total number of documents, and dfi (or
document frequency) is the number of documents the term i
appears in. This scheme emphasizes rare words, and de-
emphasizes more common words.
For every gene, we define an averaged term-vector, which is an
average of weighted term vectors from gene references and
homologous gene references. Abstracts are weighted according to
the number of genes they reference; articles referencing many
genes are down-weighted to mitigate their influence:
gik~
X
j [ ref kð Þ
wij
1
1zlog2 nref ,j
 
where gik is a the weighted count of term i for gene k, j is a
document reference for gene k, and document j references nref,j
genes. For a given gene i these gik terms define a gene-text vector.
The gene text vectors are normalized, so that their euclidean
length is 1. Pairwise gene relatedness can be calculated as the dot
product between two normalized term vectors for genes.
Keywords
To assign keywords to a collection of query regions, we first
identify the single candidate genes with the best GRAIL ptext from
each region. We then eliminate those regions where the
uncorrected GRAIL score for the gene is ptext.0.2. We restrict
keywords to those that appear in .500 documents, contain .3
letters, and have no numbers. For each term, i, we calculate a
score which is the difference between averaged term frequencies
among candidate genes and all genes:
s ið Þ~ mean
k [ candidate genes
gikð Þ{ mean
k [ all genes
gikð Þ
The top twenty highest scoring terms are selected as keywords.
Annotation based relatedness
We defined a relatedness metric between genes based on
similarity in Gene Ontology annotation terms [27]. We downloaded
Gene Ontology structure and annotations on December 19, 2006.
In addition to human gene GO annotations, we added orthologous
gene annotations. Since GO is a hierarchically structured
vocabulary, for each gene annotation we also added all of the
more general ancestral terms. This resulted in a total of 843,898
annotations for 18,050 genes with 10,803 unique GO terms; this
corresponds to a median of 40 terms per gene. We weighted
annotations proportionally to the inverse of their frequency, so
common annotations received less emphasis. We used a weighting
scheme analogous to the one we used for word weighting:
gij~
log2
NG
gfi
 
GOij~1
0 GOij~0
( )
where gij represented the weighted code i for gene j, NG is the total
number of genes, and gfi (or GO frequency) is the number of genes
annotated with the term i. Gene relatedness was the correlation
between these weighted annotation vectors.
Gene expression based relatedness
To calculate gene relatedness based on expression we download-
ed the Novartis Gene Expression Atlas [28]. The data set consists of
measurements for 33,689 probes across 158 conditions. Probes were
averaged into 17,581 gene profiles. Gene relatedness was calculated
as the correlation between expression vectors.
Lipid and height applications
We applied GRAIL to score 19 lipid-associated SNPs and
separately to score 42 height-associated SNPs. Specific SNPs are
listed in Table S1 and Table S2. We used the SNP sets as both the
seed and the query set to look for relatedness between genes across
regions. We scored SNPs separately using text, annotation, and
expression similarity metrics. We compiled the best candidate
genes and scores for the SNP regions.
Crohn’s disease application
Prior to replication, we had access to 74 independent SNP
regions that had emerged from a meta-analysis of Crohn’s Disease.
All 74 SNPs were used as both the query set and as the seed set into
GRAIL. We assessed whether those SNPs that replicated had
different text-based significance values than those that fail to
replicate. To identify additional regions of interest, we identified
the next 75 most significant regions in the Crohn’s disease meta-
analysis – they were used in GRAIL as a query set; for the seed set
included all SNPs that did not fail in replication.
Schizophrenia application
We identified singleton deletions or confirmed de novo deletions
reported by one of three groups. We selected those deletions that
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were in cases only or in controls only, were at least 100 kb large,
and included at least one gene. We obtained singleton deletions
online published by the International Schizophrenia Consortium
(2008) at [8]. We obtained de novo deletions published by Xu et al
(2008) from Table 1 [10]. We obtained singleton deletions
published in Walsh et al (2008) from Table 2 [9]. We identified
a total of 165 case-only deletions and 122 control-only deletions.
We applied the GRAIL algorithm separately to case and controls.
We speculated that the case deletions might hit genes from a
common pathway and GRAIL p-values may therefore be enriched
for significant scores. On the other hand, we hypothesized that
control deletions might be located effectively at random, and so no
particular pathway or common function should necessarily be
enriched in this collection.
To examine genes for tissue specific expression in the CNS
system, we obtained a large publicly available human tissue
expression microarray panel (GEO accession: GSE7307) [30]. We
analyzed the data using the robust multi-array (RMA) method for
background correction, normalization and polishing [55]. We
filtered the data excluding probes with either 100% ‘absent’ calls
(MAS5.0 algorithm) across tissues, expression values ,20 in all
samples, or an expression range ,100 across all tissues. To
represent each gene, we selected the corresponding probe with the
greatest intensity across all samples. The data contained expression
profiles for 19,088 genes. We included expression profiles from
some 96 normal tissues and excluded disease tissues and treated
cell lines. We averaged expression values from replicated tissues
averaged into a single value. To assess whether genes had
differential expression for CNS tissues, we compared the 27 tissue
profiles that represented brain or spinal cord to the remaining 69
tissue profiles with a one-tailed Mann-Whitney rank-sum test.
Genes obtaining p,0.01 were identified as preferentially ex-
pressed.
Evaluation against other published methods
We compared GRAIL’s performance in its ability to prospec-
tively predict Crohn’s associations to five other published methods.
The selection of these methods, and the evaluation is detailed in
Text S1.
Software
An online version of this method is available (http://www.
broad.mit.edu/mpg/grail/).
Supporting Information
Figure S1 GRAIL p-value scores for random SNPs. We scored
100 random groups of 50 SNPs with GRAIL. The y-axis is the
fraction of SNPs in the group with values below the threshold, the x-
axis lists the specific threshold. For each threshold, we plot the
distribution of the fraction of the 50 SNPs below that threshold as a
box plot. The bar is the median - the mean value is explicitly listed
below the box-plot. The box at each threshold lists the 25%–75%
range. The error-bars line depicts the 1.5 inter-quartile range. The
black dots illustrate outliers outside the 1.5 inter-quartile range.
Found at: doi:10.1371/journal.pgen.1000534.s001 (0.39 MB PDF)
Figure S2 Sensitivity versus specificity for prioritization algorithms.
We used 5 algorithms to score the 74 most promising putative SNP
associations from the Crohn’s meta-analysis study. We assessed each
algorithm’s ability to predict those SNP associations that ultimately
validated in follow-up genotyping. For each algorithm, we created a
received-operator curve (ROC).
Found at: doi:10.1371/journal.pgen.1000534.s002 (0.40 MB PDF)
Table S1 19 Lipid regions scored with Text based GRAIL
strategy. Here we scored 19 SNPs, associated with lipid metabolism.
In the first three columns we list information about the SNP. In the
fourth column we list the number of genes in the SNP associated
regions. In the fifth column we list the highest scoring gene in the
associated region based on GRAIL using a text-based metric. In the
sixth column we list the ptext values for the associated regions. We
have bolded those candidate genes that are known likely causative
gene. The seventh and eight columns list similar results for GRAIL
with an GO annotation-based metric. The ninth and tenth columns
list similar results for GRAIL with an expression-based metric.
Found at: doi:10.1371/journal.pgen.1000534.s003 (0.15 MB
DOC)
Table S2 42 Height regions scored with Text based GRAIL
strategy. Here we scored 42 SNPs, associated with height. In the first
three columns we list information of the SNP. In the fourth column
we list the number of genes in the SNP associated regions. In the
fifth column we list the highest scoring gene in the associated region
for the SNP based on GRAIL using a text-based metric. In the sixth
column we list the ptext values for the associated regions. The seventh
and eight columns list similar results for GRAIL with an annotation-
based metric. The ninth and tenth columns list similar results for
GRAIL with an expression-based metric.
Found at: doi:10.1371/journal.pgen.1000534.s004 (0.28 MB
DOC)
Table S3 Keywords for Lipid and Height SNPs. We identified
keywords associated with lipid and height associated SNPs; here
we list the top 20.
Found at: doi:10.1371/journal.pgen.1000534.s005 (0.06 MB
DOC)
Table S4 Crohn’s Disease SNPs from a meta-analysis of GWA
studies. Here we list GRAIL results and summarize genotyping
results for Crohn’s disease SNPs. These 74 SNPs emerged from a
meta-analysis and as a result of replication genotyping, they were
either validated (A), indeterminate (B), or failed (C). For each of
the regions we list the SNP ID and the chromosome in the second
and third column. In the fourth column we list the final combined
association significance score of the SNP to the Crohn’s disease. In
the fifth, sixth, and seventh columns we list GRAIL results
including the number of genes in the region, the best candidate
gene, and the text-based significance score for the region.
Found at: doi:10.1371/journal.pgen.1000534.s006 (0.21 MB
DOC)
Table S5 Algorithms to prioritize candidate genes. Our search
of the literature identified nine algorithms that could be used to
prioritize genes for replication. Four methods require no user-
specified disease information (supervised), and five require some
disease information from the user. We list in each row the name of
the disease, the website, the necessary genetic data, the functional
data used to prioritize genes, the disease-specific information that
must be included, and the availability of the method.
Found at: doi:10.1371/journal.pgen.1000534.s007 (0.09 MB
DOC)
Table S6 Performance measures for prioritization algorithms.
We used five algorithms (column 1) to score putatively associated
SNPs from the Crohn’s meta-analysis. After calculating an ROC
curve for each algorithm, we calculated the AUC (column 2). We
also calculated a p-value with a one-tailed rank-sum test
comparing the median rank of the validated SNPs to the median
rank of the failed SNPs (column 2).
Found at: doi:10.1371/journal.pgen.1000534.s008 (0.04 MB
DOC)
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Table S7 Other promising regions in Crohn’s Disease GWA
meta-analysis. Information about the top six regions identified by
GRAIL from the next 75 most significant regions from the
Crohn’s GWA study. All associations are indeterminate, and
association p-values are taken from the GWA meta-analysis - these
regions have not yet been replicated.
Found at: doi:10.1371/journal.pgen.1000534.s009 (0.05 MB
DOC)
Table S8 Rare or de novo schizophrenia control deletions. Here
we list all of the deletions that GRAIL identified as most related to
other deleted genes (ptext,0.05). For each deletion we list the
chromosome, the range of the deletion, the GRAIL p-value for the
region, and the best candidate gene in the region identified by
GRAIL. Most genomic coordinates are listed in HG17. * HG18
coordinates.
Found at: doi:10.1371/journal.pgen.1000534.s010 (0.06 MB
DOC)
Text S1 A. Random SNP groups; B. Comparison of GRAIL to
other related algorithms.
Found at: doi:10.1371/journal.pgen.1000534.s011 (0.09 MB
DOC)
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